Shuxiao Dong Selected Research

Bloom syndrome protein

1/2022	Retraction notice to miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein [Oncology Research 26(7) (2018) 1113-1121].
1/2018	miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuxiao Dong Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2018
2	Carcinogenesis 01/2022 - 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2019

Drug/Important Bio-Agent (IBA)

2	Bloom syndrome proteinIBA 01/2022 - 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Biological ProductsIBA 05/2019
1	Long Noncoding RNAIBA 05/2019
1	MicroRNAs (MicroRNA)IBA 01/2018

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
1	Therapeutics 01/2021